The founder and former leader of Inhibikase Therapeutics is blazing a new biotech trail in an effort to get a beleaguered ...

Researchers have discovered how to block cells dying, in a finding that could lead to new treatments for neurodegenerative conditions like Parkinson's and Alzheimer's. The team has identified a small ...

First Cohort Completed in PRECISE-AD Trial Evaluating PMN310 in Alzheimer's Disease Six Month Interim Results Expected in 1H 2026 Topline Results Anticipated by end of 2026 CAMBRIDGE, Massachusetts ...

That beautiful view of green fairways might be hiding a dangerous secret: people who live near golf courses face a much ...

A 2012 study reported in the New England Journal of Medicine states that tai chi, a balanced-based exercise training, ...

Presentations will be available on the Alterity Therapeutics website here.

Announced in early January 2025, ProMIS initiated PRECISE-AD based on the encouraging results from the Phase 1a trial of ...

GT-02287 protects dopaminergic neurons against mitochondrial toxin MPP+ suggesting an action on mitochondrial GCase in addition to its improvement of lysosomal GCase activityBETHESDA, Md., May 12, ...

University of Dundee scientists have discovered a new target that could herald the development of new drugs to treat ...

The authors of a recent study said their findings suggest pesticides used on golf courses to maintain the turf's health and ...

In This Corner is a local nonprofit affiliate of the national Rock Steady Boxing program to help those suffering from ...

Consuming around 11 servings of ultraprocessed food daily could more than double the risk of developing early signs of Parkinson's disease, according to a new study. The research links foods such as ...